MediFind found 5 doctor with experience in Relapsed Refractory Multiple Myeloma (RRMM) near Sheboygan, WI. Of these, 4 are Experienced and 1 are Advanced.
Vince Lombardi Cancer Clinic
Kun Xiao is a Hematologist and an Oncologist in Sheboygan, Wisconsin. Dr. Xiao is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Appendix Cancer, Essential Thrombocythemia, Chronic Lymphocytic Leukemia (CLL), Small Cell Lung Cancer (SCLC), and Bone Marrow Transplant.
St. Nicholas Hospital-Sisters Of The Third Order Of St Francis
Joshua Riebe is a Radiologist in Sheboygan, Wisconsin. Dr. Riebe is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Ureterocele, Relapsed Refractory Multiple Myeloma (RRMM), Neuroendocrine Tumor, Pleurisy, and Bone Marrow Aspiration. Dr. Riebe is currently accepting new patients.
Cheruppolil Santhosh-Kumar is a Hematologist Oncology specialist and a Hematologist in Sheboygan, Wisconsin. Dr. Santhosh-Kumar is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Clear Cell Sarcoma.
H Matthews is a Hematologist Oncology specialist and a Hematologist in Sheboygan, Wisconsin. Dr. Matthews is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Myelodysplastic Syndrome (MDS), Childhood Iron Deficiency Anemia, Intraductal Papilloma, and Small Cell Lung Cancer (SCLC). Dr. Matthews is currently accepting new patients.
Sheboygan Physicians Group S.C.
Steven Bettag is an Oncologist and a Hematologist in Sheboygan, Wisconsin. Dr. Bettag is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Lung Cancer, and Myelodysplastic Syndrome (MDS).
Last Updated: 10/30/2025
